Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2023-08-09 Major Shareholding Noti…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
SPH Notice – BlackRock, Inc. and related bodies corporate
Major Shareholding Notification Classification · 100% confidence The document is a disclosure of a substantial holding under the Financial Markets Conduct Act 2013, indicating that BlackRock, Inc. and related bodies corporate have acquired a significant shareholding (5.885%) in Pacific Edge Ltd. It includes details of the number of shares held, nature of interest, and transactions leading to the substantial holding. This type of document is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document length is 3737 characters, which is consistent with a detailed notification rather than a brief announcement or a full report. There is no indication that this is an annual report, earnings release, or any other type of filing. Therefore, the correct classification is MRQ with high confidence.
2023-08-09 English
D&O Disclosure – Bryan Williams
Director's Dealing Classification · 100% confidence The document is a disclosure notice regarding directors and senior managers' relevant interests in shares, including details of transactions by a director acquiring shares. It references the Financial Markets Conduct Act 2013 and provides transaction dates and shareholding changes. The document includes a certification statement by the director. There are no financial statements, earnings data, or management discussion of financial results. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is about 5,496 characters, which is sufficient for a detailed disclosure but not a full financial report. Therefore, the correct classification is Director's Dealing (DIRS).
2023-08-07 English
NZX - D&O Disclosure - Bryan Williams 2 pages 430.4KB
Director's Dealing Classification · 100% confidence The document is a disclosure notice regarding directors and senior managers' relevant interests in shares, including details of transactions such as on-market purchases. It references sections of the Financial Markets Conduct Act 2013 and provides specific transaction dates and shareholding changes. The document is a formal notification of insider share transactions by a director, Bryan Raymond George Williams. There is no financial performance data, earnings information, or report publication mentioned. The content fits the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The document length is about 5,496 characters, which is consistent with a detailed insider transaction disclosure rather than a full financial report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2023-08-07 English
D&O Disclosures – Chris Gallaher & Grant Gibson
Director's Dealing Classification · 95% confidence The document is a disclosure notice regarding directors and senior managers' relevant interests in the company's shares, including details of on-market purchases and shareholdings. It references sections of the Financial Markets Conduct Act 2013 and provides transaction details, dates, and certification by the director. There is no financial performance data, earnings information, or report content. The document is a report of personal share transactions by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is about 5338 characters, which is sufficient for a detailed disclosure. Therefore, the appropriate classification is DIRS with high confidence.
2023-08-03 English
NZX - D&O Disclosures - Chris Gallaher & Grant Gibson 4 pages 1.1MB
Director's Dealing Classification · 100% confidence The document is titled 'Ongoing Disclosure Notice' and contains detailed disclosures of directors and senior managers' relevant interests in the company's shares, including dates, transaction types (on market purchases), number of shares before and after transactions, and certification statements. It references sections of the Financial Markets Conduct Act 2013, indicating regulatory compliance for insider trading disclosures. The content focuses on personal share transactions by company directors and senior managers, including acquisition details and confirmations of prior written clearance during closed periods. There is no financial performance data, earnings information, or report publication announcements. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive transaction details, not just a brief notice or certification. Therefore, the correct classification is DIRS (Director's Dealing).
2023-08-02 English
Novitas Releases New Draft LCD
Regulatory Filings Classification · 95% confidence The document is a press release dated 28 July 2023 from Pacific Edge regarding the release of a new draft Local Coverage Determination (LCD) by Novitas, a Medicare Administrative Contractor. The content focuses on regulatory updates about Medicare reimbursement policies for the company's Cxbladder tests, including details about the notice and comment period, an open public meeting, and the company's response strategy. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement about regulatory and reimbursement developments rather than a financial report or detailed investor presentation. It does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. It is also not a certification or legal proceeding report. Given the nature of the content—an update on regulatory and reimbursement status—it best fits into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length (5608 characters) and detailed content confirm it is not a brief report publication announcement but a substantive regulatory update.
2023-07-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.